ACH-0144471

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ACH-0144471, covering 2022-08-11 to 2023-03-14. Get the full timeline:

Most recent: Clinical Trial Update: A Long-Term Treatment Study of ACH-0144471 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) [Phase 2]

See pricing